Corrigendum to “Angiogenesis in Pituitary Adenomas: Human Studies and New Mutant Mouse Models”

Cristina, Carolina; Luque, Guillermina M.; Demarchi, Gianina; Vicchi, Felicitas Lopez; Zubeldía-Brenner, Lautaro; Millán, María Inés Pérez; Perrone, Sofia; Ornstein, Ana María; Lacau-Mengido, I.M.; Berner, S.; Becú-Villalobos, Damasia

doi:10.1155/2020/8978014

Cited by 1 publication

(1 citation statement)

References 2 publications

(2 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cristina C. et al associated strong FGF-2 immunopositivity with invasive prolactinomas resistant to dopamine agonists. Furthermore, the expression of the FGF-2 receptor was higher in invasive tumors than in non-invasive ones [109].…”

Section: Fibroblast Growth Factorsmentioning

confidence: 89%

Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy

Tapoi,

Popa,

Tanase

et al. 2023

Cancers

View full text Add to dashboard Cite

Adenohypophysal pituitary tumors account for 10–15% of all intracranial tumors, and 25–55% display signs of invasiveness. Nevertheless, oncology still relies on histopathological examination to establish the diagnosis. Considering that the classification of pituitary tumors has changed significantly in recent years, we discuss the definition of aggressive and invasive tumors and the latest molecular criteria used for classifying these entities. The pituitary tumor microenvironment (TME) is essential for neoplastic development and progression. This review aims to reveal the impact of TME characteristics on stratifying these tumors in view of finding appropriate therapeutic approaches. The role of the pituitary tumor microenvironment and its main components, non-tumoral cells and soluble factors, has been addressed. The variable display of different immune cell types, tumor-associated fibroblasts, and folliculostellate cells is discussed in relation to tumor development and aggressiveness. The molecules secreted by both tumoral and non-tumoral cells, such as VEGF, FGF, EGF, IL6, TNFα, and immune checkpoint molecules, contribute to the crosstalk between the tumor and its microenvironment. They could be considered potential biomarkers for diagnosis and the invasiveness of these tumors, together with emerging non-coding RNA molecules. Therefore, assessing this complex network associated with pituitary neuroendocrine tumors could bring a new era in diagnosing and treating this pathology.

show abstract

Section: Fibroblast Growth Factorsmentioning

confidence: 89%